Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Nebraska Cancer Specialists: Regional Cancer Center at St. Francis Campus

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Nebraska Cancer Specialists (NCS) is a community-based oncology practice in Nebraska, USA, providing comprehensive cancer care alongside clinical research. Its research program offers patients access to clinical trials evaluating new cancer treatments, including investigational drugs, targeted therapies, and immunotherapies. Studies cover a range of malignancies, including breast, lung, colorectal, prostate, pancreatic, and hematologic cancers. The practice’s oncologists and dedicated research staff support patient screening and enrollment, study coordination, treatment monitoring, and protocol compliance. Through collaborations with research sponsors and clinical trial networks, NCS contributes to the development of new cancer therapies while expanding access to clinical research within the community.

Business Status

Source: Google. OPEN

Business Category

Source: Google. Cancer treatment center

Business Subcategory

Source: Google. Cancer treatment center
Source: Google. Hematologist
Source: Google. Medical clinic
Source: Google. Oncologist
Source: Trial-derived.
145Total Trials
Source: Trial-derived.
7Recruiting Trials
Source: Trial-derived.
97Active Trials
Source: Trial-derived.
27Completed Trials
Source: Trial-derived.
867Unique Conditions
Source: Trial-derived.
40Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Recurrent Ovarian Carcinoma (8)Source: Trial-derived. Malignant Solid Neoplasm (7)Source: Trial-derived. Chronic Lymphocytic Leukemia (6)Source: Trial-derived. Invasive Breast Carcinoma (6)Source: Trial-derived. Recurrent Breast Carcinoma (6)Source: Trial-derived. Stage IV Lung Cancer AJCC v8 (6)Source: Trial-derived. Clinical Stage III Cutaneous Melanoma AJCC v8 (5)Source: Trial-derived. Clinical Stage IV Cutaneous Melanoma AJCC v8 (5)

Sponsors

Source: Trial-derived. National Cancer Institute (NCI) (127)Source: Trial-derived. NRG Oncology (28)Source: Trial-derived. ECOG-ACRIN Cancer Research Group (9)Source: Trial-derived. Alliance for Clinical Trials in Oncology (8)Source: Trial-derived. SWOG Cancer Research Network (8)Source: Trial-derived. Canadian Cancer Trials Group (6)Source: Trial-derived. Genentech, Inc. (3)Source: Trial-derived. Merck Sharp & Dohme LLC (3)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. CT Scan
Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. MRI
Source: AI-inferred. PET-CT
Source: AI-inferred. Echocardiography
Source: AI-inferred. SPECT / nuclear medicine
Source: AI-inferred. Full pulmonary function lab (DLCO / plethysmography)
Source: AI-inferred. Spirometry

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Biobanking
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Sequencing / genomics
Source: AI-inferred. Circulating tumour DNA testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)
Source: AI-inferred. Radiation therapy
Source: AI-inferred. Radiopharmaceutical handling and administration
Source: AI-inferred. Surgery / operating room
Source: AI-inferred. Bone marrow biopsy
Source: AI-inferred. Intensity-modulated radiation therapy
Source: AI-inferred. Blood transfusion service

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Amenities

Amenities Available

Source: Google. Restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. CD4 lymphocyte enumeration
Source: AI-inferred. Cystoscopy
Source: AI-inferred. Left ventricular ejection fraction assessment
Source: AI-inferred. CD4 T-cell enumeration
Source: AI-inferred. EGFR mutation testing
Source: AI-inferred. Gut microbiome profiling
Source: AI-inferred. HIV viral-load testing
Source: AI-inferred. Laryngopharyngoscopy